Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 17:10:439.
doi: 10.3389/fnagi.2018.00439. eCollection 2018.

Differential Associations of IL-4 With Hippocampal Subfields in Mild Cognitive Impairment and Alzheimer's Disease

Affiliations

Differential Associations of IL-4 With Hippocampal Subfields in Mild Cognitive Impairment and Alzheimer's Disease

Virginia Boccardi et al. Front Aging Neurosci. .

Abstract

Background/Aims: We aimed to assess the association between in volumetric measures of hippocampal sub-regions - in healthy older controls (HC), subjects with mild cognitive impairment (MCI) and AD- with circulating levels of IL-4. Methods: From AddNeuroMed Project 113 HC, 101 stable MCI (sMCI), 22 converter MCI (cMCI) and 119 AD were included. Hippocampal subfield volumes were analyzed using Freesurfer 6.0.0 on high-resolution sagittal 3D-T1W MP-RAGE acquisitions. Plasmatic IL-4 was measured using ELISA assay. Results: IL-4 was found to be (a) positively associate with left subiculum volume (β = 0.226, p = 0.037) in sMCI and (b) negatively associate with left subiculum volume (β = -0.253, p = 0.011) and left presubiculum volume (β = -0.257, p = 0.011) in AD. Conclusion: Our results indicate a potential neuroprotective effect of IL-4 on the areas of the hippocampus more vulnerable to aging and neurodegeneration.

Keywords: Alzheimer’s disease; aging; inflammation; inflammatory markers; mild cognitive impairment.

PubMed Disclaimer

References

    1. Annenkov A. (2009). The insulin-like growth factor (IGF) receptor type 1 (IGF1R) as an essential component of the signalling network regulating neurogenesis. Mol. Neurobiol. 40 195–215. 10.1007/s12035-009-8081-0 - DOI - PubMed
    1. Barrientos R. M., Kitt M. M., Watkins L. R., Maier S. F. (2015). Neuroinflammation in the normal aging hippocampus. Neuroscience 309 84–99. 10.1016/j.neuroscience.2015.03.007 - DOI - PMC - PubMed
    1. Bellinger F. P., Madamba S., Siggins R. (1993). Interleukin 1/3 inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 628 227–234. 10.1016/0006-8993(93)90959-Q - DOI - PubMed
    1. Boutet C., Chupin M., Lehéricy S., Marrakchi-Kacem L., Epelbaum S., Poupon C., et al. (2014). Detection of volume loss in hippocampal layers in Alzheimer’s disease using 7 T MRI: a feasibility study. NeuroImage Clin. 5 341–348. 10.1016/j.nicl.2014.07.011 - DOI - PMC - PubMed
    1. Butovsky O., Ziv Y., Schwartz A., Landa G., Talpalar A. E., Pluchino S., et al. (2006). Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell. Neurosci. 31 149–160. 10.1016/j.mcn.2005.10.006 - DOI - PubMed

LinkOut - more resources